Christopher Whitfield
InvestorPartner at Syridex Bio · Strategic Advisor at 2Flo Ventures · Chief Executive Officer at Antigenix Therapeutics
Indianapolis, Indiana, United States
Find your path to Christopher
185 people in our graph share verified history with Christopher — schools, employers, funds. One of them is your warm intro.
Sian CathrallunlockedChristopher: together at University of Cape Town (2005–2006)
×2Christopher: together at Duke University - The Fuqua School of Business
×7Christopher: together at Santa Clara University Leavey School of Business
×2Christopher: together at Wabash College
About
Christopher Whitfield is Chief Executive Officer of Antigenix Therapeutics, a spinout company developing antibody-based oncology therapies. He brings over 25 years of biopharmaceutical leadership experience, including 17 years at Eli Lilly and Company where he served as CEO of Eli Lilly South Africa, and a tenure as Executive Director and Regional General Manager for Africa at Gilead Sciences. Whitfield has founded and scaled multiple healthcare companies focused on African market expansion and also serves as an advisor to venture capital and private equity firms on healthcare transactions and strategy.
Chief Executive Officer at Antigenix Therapeutics
Experience
- Antigenix TherapeuticsChief Executive Officercurrent2024 — presentIndianapolis, Indiana, United States
- Temprian Oncology IncorporatedSenior Advisorcurrent2024 — present
- Syridex BioPartnercurrent2024 — present
- OneWe Reach (formerly WOCIP®)Member of the Board of Advisorscurrent2022 — presentGlobal
- Egg Healthy PregnancyCorporate Advisorcurrent2022 — present
- NeuroX1 Inc.Advisory Board Member2023 — 2025United States
- Gilead SciencesExecutive Director and General Manager, Africa Region2021 — 2023Africa
- African Clinical Research Organisation (Pty) LtdFounder, Member Board of Directors2007 — 2020Johannesburg Metropolitan Area
- Batswadi Group of CompaniesFounder, Chairman of the Board of Directors and Chief Executive officer2006 — 2018Africa
- EndeavorMember Board of Directors2008 — 2013South Africa
- Eli Lilly and CompanyCEO and General Manager2001 — 2005Johannesburg Metropolitan Area
- Eli Lilly and CompanyDirector1988 — 2001Greater Indianapolis
Skills & more
Biotechnology49Pharmaceuticals7Oncology47Business StrategyStrategic Planning62Marketing Strategy19Entrepreneurship88Product Development5New Business Development18Business Planning15Strategy Development1Research4
+8 more
Management ConsultingHealthcareSales ManagementLeadership DevelopmentCommercializationCross-functional Team LeadershipBusiness DevelopmentCompetitive Analysis- Member — YPO
- Agile Certified Professional — The International Consortium for Agility
From Christopher's professional profile.
Colleagues at Syridex Bio
Anindya Roychowdhury
Investor at Syridex Bio
Ben Duster
Investor at Syridex Bio
Charles Corpening
Investor at Syridex Bio
Christopher Whitfield
Advisory Partner at Syridex Bio
Hyunki Kim
Managing Director at Stonebridge Ventures
Joshua Adeoye
Principal at Syridex Bio
Kamil Ali-Jackson
Investor at Syridex Bio
Owen May
Investor at Syridex Bio
Frequently asked questions
- Who is Christopher Whitfield?
- Christopher Whitfield is Chief Executive Officer of Antigenix Therapeutics, a spinout company developing antibody-based oncology therapies. He brings over 25 years of biopharmaceutical leadership experience, including 17 years at Eli Lilly and Company where he served as CEO of Eli Lilly South Africa, and a tenure as Executive Director and Regional General Manager for Africa at Gilead Sciences. Whitfield has founded and scaled multiple healthcare companies focused on African market expansion and also serves as an advisor to venture capital and private equity firms on healthcare transactions and strategy.
- Where does Christopher Whitfield work?
- Christopher Whitfield is Partner at Syridex Bio and Chief Executive Officer at Antigenix Therapeutics.
- Where did Christopher Whitfield go to school?
- Christopher Whitfield studied at Duke University - The Fuqua School of Business (MBA, Global Management); Boston University School of Public Health (Executive Education, Development of Global Health Outcomes); Santa Clara University Leavey School of Business (Black Corporate Board Readiness, Marketing).
Founder mafias
University of Cape Town mafia66
Also came through, then founded or led a company.
Daniel ChalefBachelor of Business ScienceFounded KnowledgeTree +1Kiaan PillayBachelor's DegreeFounded Stitch +1Tim ChambersBAFounded Offgrid +1Laurence WattrusBSc Electro-Mechanical EngineeringFounded Hammerhead +1Meg FaureBachelor of Science (B.Sc.)Founded Parent Sense +1Ian LessemBachelor of Business ScienceFounded Havaic
+ 59 more
Duke University - The Fuqua School of Business mafia57
Also came through, then founded or led a company.
Chat JoglekarMBAFounded Baton +2Jonathan ViolinM.B.A.Founded Viridian Therapeutics +2Corinna ChenMBAFounded Tierra Biosciences +1Melinda French GatesMaster of Business Administration - MBAFounded Gates Foundation +1Jacopo LeonardiMBAFounded 4D Path +1Christopher MortonMBAFounded SlidePay +1
+ 50 more
Santa Clara University Leavey School of Business mafia11
Also came through, then founded or led a company.
George ManuelianMBAFounded RapidFortDavid SacarelosExecutive MBAFounded Orbital CompositesLuis ManriqueFinanceFounded Understudy LabsAjeet SinghMBAFounded ThoughtSpotRitesh PatelFounded NirmataLuca RossettiniCertificate in Technology EntrepreneurshipFounded D-Orbit
+ 4 more
Wabash College mafia7
Also came through, then founded or led a company.
2Flo Ventures mafia3
Also came through, then founded or led a company.
Same school
Also attended Duke University - The Fuqua School of Business252
Dave BlivinMANAGING PARTNER at Cottonwood Technology FundBrooke BalcomBoard Member at CincyTechChad SummeBoard Member at CincyTechTracie RotterPartner, Platform at Lux CapitalUlili OnovakpuriManaging Partner at Kapor CapitalLindsay MehtaDirector, Investor Relations & Marketing at JMI Equity
+ 246 more
Also attended Boston University School of Public Health4
Also attended Santa Clara University Leavey School of Business52
HowardAdvisor at Clear VenturesMary DentenChief Financial Officer at Scale Venture PartnersKristin DrewChief Financial Officer at CapitalGConnie ShengCo-Founder & Managing Director at Nautilus Ventures Management Company (Us), LlcGeorge ManuelianAdvisory Board Member at Rembrandt Venture PartnersJohn DelfinoPartner, General Counsel at TCV
+ 46 more
Also attended Wabash College17
Kyle PrifogleStaff AI Engineer at JMI EquityMichael KrutzPrincipal at Barrel VenturesMichael NogenPartner at Overton Venture CapitalMicah WalkerInvestment Associate at Innoventures IowaMatthew JessupAI & Digital Asset Analyst at Sarson FundsDerrick LiPrincipal at Afore Capital
+ 11 more
Shared employers
Also worked at OneWe Reach (formerly WOCIP®)1
Also worked at Gilead Sciences32
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionKate ButlerInvestor at Syncona
+ 26 more
Also worked at Endeavor322
Vinnie LauriaFounding Partner at Golden Gate VenturesSaraInvestor at Maven Ventures focused on consumer softwarePeter KellnerManaging Partner of Richmond GlobalLily SarafanInvestor at Streamlined VenturesPablo VenturaInvestor at KfundAntonia Rojas EingFounder & Managing Partner at ATTOM CAPITAL
%20(1).png)
+ 316 more
Also worked at Eli Lilly and Company120
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 114 more